Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs

48Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca2+ and Mg2+) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.

Cite

CITATION STYLE

APA

Vassaki, M., Papathanasiou, K. E., Hadjicharalambous, C., Chandrinou, D., Turhanen, P., Choquesillo-Lazarte, D., & Demadis, K. D. (2020). Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs. Chemical Communications, 56(38), 5166–5169. https://doi.org/10.1039/d0cc00439a

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free